Mercury Laboratories Ltd

Mercury Laboratories Ltd has announced the closure of its trading window for designated persons and their relatives. This closure is in accordance with SEBI regulations and the company's internal code of conduct. The trading window will be shut effective July 1, 2026, and will reopen 48 hours after the announcement of the unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to consider these results will be communicated separately.

Mercury Laboratories Ltd has announced the appointment of Mr. Binaya Kumar Panigrahi as the new Plant Head for its Jarod Unit. The appointment is effective from June 11, 2026. Mr. Panigrahi, aged 52, holds a Bachelor's degree in Pharmacy and brings over 24 years of experience in Tablet Manufacturing, having previously worked with Coral Laboratories Limited and Biocon Biological India Limited. This appointment is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mercury Laboratories Ltd has issued a corrigendum to its audited financial results for the quarter and year ended March 31, 2026, due to a typographical error in the balance sheet under current liabilities and an omission in cash flow from financing activities. The corrected financial results, along with the auditor's report, have been resubmitted. The board had earlier recommended a final dividend of 35% i.e ₹3.50 per share for FY26, subject to shareholder approval.

Mercury Laboratories Ltd has appointed M/s K R & Associates as Internal Auditor and M/s V. M. Patel & Associates as Cost Auditor for the financial year 2026-27. The appointments were approved by the Board of Directors on May 29, 2026. M/s K R & Associates, a partnership firm established in 2009, will handle internal auditing, while M/s V. M. Patel & Associates, practicing since 2012, will oversee cost audits.

Mercury Laboratories Ltd. has announced a book closure from September 22, 2026, to September 28, 2026, for its 45th Annual General Meeting and the payment of a final dividend. The AGM is scheduled for September 28, 2026. The proposed final dividend is ₹3.5 (35.00%) per equity share, subject to member approval at the AGM. The record date for the dividend is September 21, 2026.

Mercury Laboratories Ltd's Board of Directors recommended a final dividend of ₹3.50 per share (35%) on the equity share capital for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting. The Board also approved the audited financial results for the quarter and financial year ended March 31, 2026. The 45th Annual General Meeting will be held on September 28, 2026, via video conferencing. The register of members and share transfer books will be closed from September 22, 2026, to September 28, 2026, with a record date of September 21, 2026, for dividend payment. The dividend, if declared, will be paid on or before October 26, 2026.

Mercury Laboratories Ltd approved audited financial results for the year ended March 31, 2026. The Board recommended a final dividend of 35% (₹3.50 per share) for FY26, subject to shareholder approval. M/s K R & Associates and M/s V. M. Patel & Associates were re-appointed as Internal Auditor and Cost Auditor, respectively, for FY27. The 45th Annual General Meeting will be held on September 28, 2026, via video conferencing. The register of members will be closed from September 22 to September 28, 2026, with a record date of September 21, 2026, for the dividend payment.

Mercury Laboratories Ltd approved the audited financial results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of 35% (₹3.50 per share) on equity shares for the year 2025-26, subject to shareholder approval. They re-appointed M/s K R & Associates as Internal Auditor and M/s V. M. Patel & Associates as Cost Auditor for FY 2026-27. The 45th Annual General Meeting will be held on September 28, 2026, via video conferencing. The register of members and share transfer books will be closed from September 22, 2026, to September 28, 2026, with a record date of September 21, 2026, for the dividend.

Mercury Laboratories Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend for the year, subject to shareholder approval. The trading window has been closed since April 1, 2026, and will remain closed until 48 hours after the declaration of the results.

Mercury Laboratories Ltd announced the resignation of Mr. Sandip Patel, Plant Head-Jarod, who was designated as Senior Management Personnel (SMP). Mr. Patel tendered his resignation citing "better opportunities and career advancement." The company confirmed that there are no other material reasons for his departure. His resignation will be effective from the closure of business hours on April 28, 2026. The company has provided the necessary disclosures as per SEBI (LODR) Regulations, 2015.